Paul Tudor Jones Medpace Holdings, Inc. Call Options Transaction History

Tudor Investment Corp Et Al

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $64,116 - $91,458	200 Added 28.57%	900 $300,000
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $186,000 - $212,170	-500 Reduced 41.67%	700 $288,000
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $341,844 - $495,972	1,200 New	1,200 $484,000
Q3 2023 Nov 15, 2023	BUY	$233.98 - $281.67 $631,746 - $760,509	2,700 New	2,700 $653,000
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $45,918 - $67,971	-300 Reduced 8.33%	3,300 $701,000
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $522,468 - $656,964	3,600 New	3,600 $565,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.